Systems and methods for treatment of obesity and type 2 diabetes
The present invention provides systems and methods for treating and controlling obesity and/or type II diabetes. In one aspect of the invention, an internal bypass device includes gastric and duodenal anchors coupled to each other and positioned on either side of the pylorus and a hollow sleeve designed to extend from the pylorus through at least a proximal portion of a patient's small intestine. The gastric and duodenal anchors are movable between collapsed configurations for advancement through the esophagus and an expanded configuration for inhibiting movement of the anchors through the pyloric sphincter. Thus, the bypass device can be placed and removed endoscopically through the patient's esophagus in a minimally invasive outpatient procedure and it is “self-anchoring” and does not require invasive tissue fixation within the patient's GI tract, thereby reducing collateral tissue damage and minimizing its impact on the digestive process.
1. A device for treating obesity and/or type II diabetes in a patient comprising:
a gastric anchor inflatable between a first configuration sized and shaped for advancement through an esophagus into a selected region of a stomach of the patient and a second configuration sized and shaped to inhibit distal movement of the gastric anchor through a pyloric sphincter of the patient;
a duodenal anchor coupled to the gastric anchor and inflatable between a first configuration sized and shaped for advancement through the esophagus, the stomach and the pyloric sphincter into a proximal region of a duodenum of the patient and a second configuration sized and shaped to inhibit proximal movement of the anchor through the pyloric sphincter; and
a substantially hollow sleeve coupled to the duodenal anchor and having open proximal and distal ends and an internal lumen therebetween having a proximal end configured to be coupled to a fluid delivery source, the sleeve being sized and shaped to extend through at least a proximal portion of a duodenum of the patient and further comprising a plurality of internal lumens extending along a length of the sleeve and spaced from each other around a circumference of the sleeve.
2. The device of claim 1 wherein the sleeve further comprises a fluid chamber in close proximity to the open distal end and in fluid communication with the internal lumen.
3. The device of claim 2 wherein the fluid chamber is a substantially annular passage at the distal end of the sleeve.
4. The device of claim 1 wherein the sleeve further comprises multiple fluid chambers between the open proximal and distal ends, the fluid chambers fluidly coupled to the internal lumen.
5. The device of claim 1 wherein the hollow sleeve is sized and shaped to extend from a proximal portion of the duodenum into a jejunum of the patient.
6. The device of claim 1 wherein the gastric anchor defines an exterior wall housing an interior portion and an inlet in the exterior wall for delivering a fluid to the interior portion.
7. The device of claim 6 , wherein the gastric anchor is configured for inflation by the fluid from the first configuration to the second configuration.
8. The device of claim 1 wherein the duodenal anchor defines an exterior wall housing an interior portion and an inlet in the exterior wall for delivering a fluid to the interior portion.
9. The device of 8 , wherein the device is configured for inflation by the fluid from the first configuration to the second configuration.
10. A device for treating obesity and/or type II diabetes in a patient comprising:
a gastric anchor inflatable between a first configuration sized and shaped for advancement through an esophagus into a selected region of a stomach of the patient and a second configuration sized and shaped to inhibit distal movement of the gastric anchor through a pyloric sphincter of the patient;
a duodenal anchor coupled to the gastric anchor and inflatable between a first configuration sized and shaped for advancement through the esophagus, the stomach and the pyloric sphincter into a proximal region of a duodenum of the patient and a second configuration sized and shaped to inhibit proximal movement of the anchor through the pyloric sphincter; and
a substantially hollow sleeve coupled to the duodenal anchor and having open proximal and distal ends and an internal lumen therebetween having a proximal end configured to be coupled to a fluid delivery source and extending in a substantially spiral pattern along a length of the sleeve, the sleeve being sized and shaped to extend through at least a proximal portion of a duodenum of the patient.
11. The device of claim 10 wherein the hollow sleeve is sized and shaped to extend from a proximal portion of the duodenum into a jejunum of the patient.
12. The device of claim 10 wherein the gastric anchor defines an exterior wall housing an interior portion and an inlet in the exterior wall for delivering a fluid to the interior portion.
13. The device of claim 12 wherein the gastric anchor is configured for inflation by the fluid from the first configuration to the second configuration.
14. The device of claim 10 wherein the duodenal anchor defines an exterior wall housing an interior portion and an inlet in the exterior wall for delivering a fluid to the interior portion.
15. The device of claim 14 , wherein the device is configured for inflation by the fluid from the first configuration to the second configuration.
16. A device for treating obesity and/or type II diabetes in a patient comprising:
a gastric anchor inflatable between a first configuration sized and shaped for advancement through an esophagus into a selected region of a stomach of the patient and a second configuration sized and shaped to inhibit distal movement of the gastric anchor through a pyloric sphincter of the patient;
a duodenal anchor coupled to the gastric anchor and inflatable between a first configuration sized and shaped for advancement through the esophagus, the stomach and the pyloric sphincter into a proximal region of a duodenum of the patient and a second configuration sized and shaped to inhibit proximal movement of the anchor through the pyloric sphincter; and
a substantially hollow sleeve coupled to the duodenal anchor and having open proximal and distal ends and an internal lumen therebetween having a proximal end configured to be coupled to a fluid delivery source, the sleeve being sized and shaped to extend through at least a proximal portion of a duodenum of the patient, wherein the sleeve further comprises multiple fluid chambers between the open proximal and distal ends, the fluid chambers fluidly coupled to the internal lumen.
17. The device of claim 16 wherein the hollow sleeve is sized and shaped to extend from a proximal portion of the duodenum into a jejunum of the patient.
18. The device of claim 16 wherein the gastric anchor defines an exterior wall housing an interior portion and an inlet in the exterior wall for delivering a fluid to the interior portion.
19. The device of claim 18 wherein the gastric anchor is configured for inflation by the fluid from the first configuration to the second configuration.
20. The device of claim 16 wherein the duodenal anchor defines an exterior wall housing an interior portion and an inlet in the exterior wall for delivering a fluid to the interior portion.
21. The device of claim 20 , wherein the device is configured for inflation by the fluid from the first configuration to the second configuration.